Business Model

CTGCT (Centre for the Technologies of Gene and Cell Therapy, at National institute of Chemistry, Ljubljana) has joined the statement to preserve the Hospital Exemption in the revised EU pharmaceutical legislation. The Joint Statement, ...

In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation.

Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry.

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

The CTGCT presented the project in the 3rd Teaming Club Conference in Novi Sad, Serbia.

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...